The Boston Scientific OffRoad Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages in the major arteries that supply blood to the legs. These blockages, called chronic total occlusions (CTOs), are often associated with peripheral artery disease (PAD). The data from the Re-ROUTE clinical trial were reported in a late-breaking clinical trial session at the Vascular Interventional Advances Conference (VIVA) in Las Vegas.

Bioventrix announced the presentation of scientific data demonstrating the durability of its Revivent Myocardial Anchoring System in 24 patients one year post-procedure. The data, which Andrew Wechsler, M.D. and professor of cardiothoracic surgery, Drexel University, presented at the prestigious European Association for Cardio-Thoracic Surgery meeting in Vienna, Austria, highlighted results from the company’s Phase I clinical trial conducted at five European centers.

Mortara Instrument Inc. announced an integrated connectivity solution that provides data from the Quinton Q-Tel Rehabilitation Management Systems to the American Association of Cardiovascular and Pulmonary Rehabilitation’s (AACVPR’s) Outpatient Cardiac Rehabilitation Registry. The web-based registry is the first of its kind in the United States and will provide cardiac rehabilitation professionals with a means to track, document and communicate patient outcomes and program performance.